In April 2018, the Hong Kong Stock Exchange’s (HKEx) rule amendments permitting the listing of innovative, high-growth companies with dual-class share structures and pre-revenue biotech companies went into effect. The...more
1/23/2019
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
China ,
Dual Class Share Structures ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Shanghai Stock Exchange ,
Shenzhen Stock Exchange (SZSE) ,
Stock Connect ,
Technology Sector ,
Trade Relations